Related references
Note: Only part of the references are listed.KEGG for taxonomy-based analysis of pathways and genomes
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2023)
Cancer-associated fibroblasts-derived HAPLN1 promotes tumour invasion through extracellular matrix remodeling in gastric cancer
Tiancheng Zhang et al.
GASTRIC CANCER (2022)
Nrf2 signaling in heart failure: expression of Nrf2, Keap1, antioxidant, and detoxification genes in dilated or ischemic cardiomyopathy
Yingying Lu et al.
PHYSIOLOGICAL GENOMICS (2022)
Kansl1 haploinsufficiency impairs autophagosome-lysosome fusion and links autophagic dysfunction with Koolen-de Vries syndrome in mice
Ting Li et al.
NATURE COMMUNICATIONS (2022)
The response to cardiac resynchronization therapy in LMNA cardiomyopathy
Kiran Sidhu et al.
EUROPEAN JOURNAL OF HEART FAILURE (2022)
HAPLN1 Affects Cell Viability and Promotes the Pro-Inflammatory Phenotype of Fibroblast-Like Synoviocytes
Yong Chen et al.
FRONTIERS IN IMMUNOLOGY (2022)
Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy via a Microarray Data Analysis
Zuoxiang Wang et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Identification of potential dilated cardiomyopathy-related targets by meta-analysis and co-expression analysis of human RNA-sequencing datasets
Zixun Yuan et al.
LIFE SCIENCES (2022)
Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy
Anne-Claire Guenantin et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Integrated analysis reveals the alterations that LMNA interacts with euchromatin in LMNA mutation-associated dilated cardiomyopathy
Xiaolin Zhang et al.
CLINICAL EPIGENETICS (2021)
Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes
Parisha P. Shah et al.
CELL STEM CELL (2021)
Highly comparable metabarcoding results from MGI-Tech and Illumina sequencing platforms
Sten Anslan et al.
PEERJ (2021)
Carbonic anhydrase 2 and 3 as risk biomarkers for dilated cardiomyopathy associated heart failure
Hao Su et al.
ANNALS OF PALLIATIVE MEDICINE (2021)
Carbonic Anhydrase III Attenuates Hypoxia-Induced Apoptosis and Activates PI3K/Akt/mTOR Pathway in H9c2 Cardiomyocyte Cell Line
Hua Li et al.
CARDIOVASCULAR TOXICOLOGY (2021)
Disrupting the LINC complex by AAV mediated gene transduction prevents progression of Lamin induced cardiomyopathy
Ruth Jinfen Chai et al.
NATURE COMMUNICATIONS (2021)
Expression of Lmna-R225X nonsense mutation results in dilated cardiomyopathy and conduction disorders (DCM-CD) in mice: Impact of exercise training
Zhu-Jun Cai et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
ClinVar: improvements to accessing data
Melissa J. Landrum et al.
NUCLEIC ACIDS RESEARCH (2020)
Protease-activated receptor 2 deficiency in hematopoietic lineage protects against myocardial infarction through attenuated inflammatory response and fibrosis
Pengfei Zuo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Mutated lamin A modulates stiffness in muscle cells
Maria Chatzifrangkeskou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
The Broad Spectrum ofLMNACardiac Diseases: From Molecular Mechanisms to Clinical Phenotype
Silvia Crasto et al.
FRONTIERS IN PHYSIOLOGY (2020)
BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C deficient mice
Gaelle Auguste et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites
Sherif M. Shoieb et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy
Nazish Sayed et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
A Role for HAPLN1 During Phenotypic Modulation of Human Lung Fibroblasts In Vitro
Stephen P. Evanko et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2020)
Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction
Julian Friebel et al.
EUROPEAN HEART JOURNAL (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
Transgenic expression of carbonic anhydrase III in cardiac muscle demonstrates a mechanism to tolerate acidosis
Han-Zhong Feng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)
TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions
Heonjong Han et al.
NUCLEIC ACIDS RESEARCH (2018)
PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice
Shannon M. Jones et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Biomechanical defects and rescue of cardiomyocytes expressing pathologic nuclear lamins
Erik Laurini et al.
CARDIOVASCULAR RESEARCH (2018)
S-Enantiomer of 19-Hydroxyeicosatetraenoic Acid Preferentially Protects Against Angiotensin II-Induced Cardiac Hypertrophy
Sherif M. Shoieb et al.
DRUG METABOLISM AND DISPOSITION (2018)
The clinical outcome of LMNA missense mutations can be associated with the amount of mutated protein in the nuclear envelope
Rasha A. Al-Saaidi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
miRWalk: An online resource for prediction of microRNA binding sites
Carsten Sticht et al.
PLOS ONE (2018)
Dhcr24 activates the PI3K/Akt/HKII pathway and protects against dilated cardiomyopathy in mice
Wei Dong et al.
ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2018)
Partial microduplication in the histone acetyltransferase complex member KANSL1 is associated with congenital heart defects in 22q11.2 microdeletion syndrome patients
Luis E. Leon et al.
SCIENTIFIC REPORTS (2017)
Fibromodulin: A regulatory molecule maintaining cellular architecture for normal cellular function
Arif Tasleem Jan et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
A targeted metabolomics assay for cardiac metabolism and demonstration using a mouse model of dilated cardiomyopathy
James A. West et al.
METABOLOMICS (2016)
Do lamin A and lamin C have unique roles?
Rasha Al-Saaidi et al.
CHROMOSOMA (2015)
'State-of-the-heart' of cardiac laminopathies
Marie-Elodie Cattin et al.
CURRENT OPINION IN CARDIOLOGY (2013)
Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders
Frédéric Anselme et al.
HEART RHYTHM (2013)
Mitogen-Activated Protein Kinase Inhibitors Improve Heart Function and Prevent Fibrosis in Cardiomyopathy Caused by Mutation in Lamin A/C Gene
Wei Wu et al.
CIRCULATION (2011)
Ligand docking and binding site analysis with PyMOL and Autodock/Vina
Daniel Seeliger et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)
Long-term outcome and risk stratification in dilated cardiolaminopathies
Michele Pasotti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Cytochrome P450 and arachidonic acid metabolites:: Role in myocardial ischemia/reperfusion injury revisited
GJ Gross et al.
CARDIOVASCULAR RESEARCH (2005)
Natural history of dilated cardiomyopathy due to lamin A/C gene mutations
MRG Taylor et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Structure of the globular tail of nuclear lamin
S Dhe-Paganon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Autosomal dominant dilated cardiomyopathy with atrioventricular block: A lamin A/C defect-related disease
E Arbustini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Share Paper
